Tegan Thimesch, DPM
Foot Surgery · Chicago, ILNPI 1376511287
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,475 of the $1,845 with a category attached, or 79.9%. Johnson & Johnson accounts for 79.9% of it on its own, with 4 other manufacturers making up the rest. 2023 is the largest year on record at $1,722, more than ten times the $15 reported in 2019.
Across 6 payments — averaging $307.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Abbott$175
- Baudax Bio Inc.$109
- Next Science LLC$73
- Cook Medical LLC$15
What the payments were for
- Food & beverage$37120%
- Other$1,47580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $1,475 |
| Abbott | 1 | $175 |
| Baudax Bio Inc. | 1 | $109 |
| Next Science LLC | 2 | $73 |
| Cook Medical LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,845 in reported general payments places this provider in the 60th percentile of 51 foot surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 42 | $933 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $594 |
| Cefdinir | 54 | $452 |
| Terbinafine Hcl | 16 | $390 |
| Silver Sulfadiazine | 65 | $361 |
| Imiquimod | 17 | $245 |
| SsdSilver Sulfadiazine | 28 | $177 |
| Methylprednisolone | 27 | $126 |
| Ciprofloxacin Hcl | 29 | $87 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Chicago
- Jillian CabaiChicago$7K
- Douglas DiekeversChicago$3K
- Muriel FreemanChicago$3K
- Sloan MetzChicago$2K
- Anna PetrovChicago$717
- Angeles ValdesChicago$702
- Michael NewkirkChicago$241
- David HongChicago$49
- Darrell LatvaChicago$27
- Jeeten SinghaWestmont$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.